Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 118
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Fuel (Lond) ; 3232022 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-39309144

RESUMEN

In this study, the regulated emissions, gaseous toxics, and the physical, chemical, and toxicological properties of particulate matter (PM) emissions from a legacy off-road diesel engine operated on hydrogenated vegetable oil (HVO) and HVO blends with biodiesel were investigated. This is one of the very few studies currently available examining the emissions and potential health effects of HVO and its blends with biodiesel from diesel engines. Extended testing was conducted over the nonroad transient cycle (NRTC) and the 5-mode D2 ISO 8718 cycle. Nitrogen oxide (NOx) emissions showed statistically significant reductions for HVO compared to diesel, whereas the biodiesel blends statistically significant increases in NOx emissions. PM and solid particle number reductions with pure HVO and the biodiesel blends were also observed. Low-molecular weight polycyclic aromatic hydrocarbons (PAHs) were the dominant species in the exhaust for all fuels, with pure HVO and the biodiesel blends showing lower concentrations of these pollutants compared to diesel fuel. Our results showed that the oxidative stress and cytotoxicity in PM emissions decreased with the use of biofuels. Notable correlations were observed between PM emissions and oxidative stress and cytotoxicity, especially elemental carbon and particle-phase PAH emissions.

2.
J Strength Cond Res ; 35(Suppl 1): S1-S5, 2021 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-32032231

RESUMEN

ABSTRACT: Vantrease, WC, Townsend, JR, Sapp, PA, Henry, RN, and Johnson, KD. Maximal strength, muscle activation, and bar velocity comparisons between squatting with a traditional or safety squat bar. J Strength Cond Res 35(2S): S1-S5, 2021-The purpose of this study was to compare strength, muscle activation, and bar velocity between the traditional (TRAD) and safety squat bar (SSB) back squat. Thirty-two men (21.94 ± 3.1 years, 1.78 ± 0.8 m, 81.7 ± 10.1 kg) volunteered to complete this randomized, crossover-design study. Subjects completed 2 separate 1 repetition maximum (1RM) sessions using either the TRAD or SSB. Subsequently, subjects completed 1 session of 3 repetitions at 65 and 85% of their 1RM for each squat condition (SSB & TRAD). Peak muscle activation of 7 muscles from the lower body and trunk was recorded through surface electromyography (EMG), and mean velocity (MV) was recorded by a linear transducer. Electromyography and MV were analyzed by a 2 × 2 (bar × load) repeated-measures analysis of variance. A Pearson correlation was used to determine the relationship of 1RM load between bars. Squat 1RM was significantly higher (p < 0.001; 11.6%) for TRAD (144.7 kg) compared with SSB (128.8 kg), and a strong correlation (r = 0.94) was observed between 1RM values of each bar. A significant main effect was seen in EMG (p < 0.001) and MV for load (p < 0.001). No significant bar × load interaction was observed between conditions for any EMG or bar velocity measure (p > 0.05). The SSB produces similar muscle activation and bar velocities compared with the TRAD at relative intensities. However, absolute loads should be adjusted when changing squat bars during a training cycle.


Asunto(s)
Entrenamiento de Fuerza , Levantamiento de Peso , Humanos , Masculino , Fuerza Muscular , Músculo Esquelético , Postura , Torso
3.
J Autoimmun ; 105: 102302, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31320177

RESUMEN

OBJECTIVE: To investigate serum IL-6 (sIL-6) levels during active disease, complete remission (CR), and relapse in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), and to explore the association of changes in sIL-6 with clinical outcomes. METHODS: sIL-6 levels were measured at baseline and longitudinally over 18 months, in 78 patients with AAV enrolled in a randomized controlled trial comparing treatment with either rituximab (RTX) or cyclophosphamide (CYC)/azathioprine (AZA). Outcome variables included baseline clinical features, ANCA specificity, disease activity (active disease versus CR), time to relapse events, B cell repopulation, and ANCA titer increases. RESULTS: At baseline, sIL6 levels were detectable in 81% of patients; 73% (n = 57) of subjects were proteinase 3 (PR3)-ANCA positive, sIL-6 levels were higher in subjects with PR3-ANCAs and positively correlated with their levels (rs = 0.36,p < 0.01), but not with levels of myeloperoxidase (MPO)-ANCA (rs = -0.17,p = 0.47). Higher baseline sIL-6 levels were associated with PR3-ANCA positivity, fever, pulmonary nodules/cavities, conductive deafness, and absence of urinary red blood cell casts (p < 0.05). Baseline sIL6 levels did not predict CR at month 6 (p = 0.71), and the median sIL-6 level declined from baseline with induction therapy, regardless of CR achievement. An increase in sIL-6 during CR was a predictor for subsequent severe relapse in RTX-treated patients (hazard ratio (HR):7.24,p = 0.01), but not in CYC/AZA-treated patients (HR:0.62,p = 0.50). In contrast, a sIL-6 increase did not predict B cell repopulation or ANCA titer increase in either treatment arm (p > 0.05). CONCLUSION: At baseline, sIL-6 concentrations correlate with PR3-ANCA titers and are associated with specific clinical manifestations of AAV. Baseline sIL6 concentrations do not predict CR at 6 months, but the increase in sIL-6 concentrations during CR is associated with subsequent severe relapse among RTX-treated patients. Further investigation into the mechanistic role of IL6 in AAV might lead to identifying this pathway as a potential therapeutic target in this disease.


Asunto(s)
Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/sangre , Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/inmunología , Anticuerpos Anticitoplasma de Neutrófilos/inmunología , Citoplasma/inmunología , Interleucina-6/sangre , Neutrófilos/inmunología , Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/tratamiento farmacológico , Azatioprina/uso terapéutico , Linfocitos B/efectos de los fármacos , Linfocitos B/inmunología , Ciclofosfamida/uso terapéutico , Método Doble Ciego , Quimioterapia Combinada , Femenino , Humanos , Inmunosupresores/uso terapéutico , Interleucina-6/inmunología , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Mieloblastina/inmunología , Neutrófilos/efectos de los fármacos , Peroxidasa/inmunología , Inducción de Remisión/métodos , Rituximab/uso terapéutico
4.
Environ Sci Technol ; 53(9): 5504-5511, 2019 05 07.
Artículo en Inglés | MEDLINE | ID: mdl-30995015

RESUMEN

Real-world nitrogen oxides (NO x) emissions were estimated using on-board sensor readings from 72 heavy-duty diesel vehicles (HDDVs) equipped with a Selective Catalytic Reduction (SCR) system in California. The results showed that there were large differences between in-use and certification NO x emissions, with 12 HDDVs emitting more than three times the standard during hot-running and idling operations in the real world. The overall NO x conversion efficiencies of the SCR system on many vehicles were well below the 90% threshold that is expected for an efficient SCR system, even when the SCR system was above the optimum operating temperature threshold of 250 °C. This could potentially be associated with SCR catalyst deterioration on some engines. The Not-to-Exceed (NTE) requirements currently used by the heavy-duty in-use compliance program were evaluated using on-board NO x sensor data. Valid NTE events covered only 4.2-16.4% of the engine operation and 6.6-34.6% of the estimated NO x emissions. This work shows that low cost on-board NO x sensors are a convenient tool to monitor in-use NO x emissions in real-time, evaluate the SCR system performance, and identify vehicle operating modes with high NO x emissions. This information can inform certification and compliance programs to ensure low in-use NO x emissions.


Asunto(s)
Contaminantes Atmosféricos , Emisiones de Vehículos , California , Catálisis , Vehículos a Motor , Óxidos de Nitrógeno
5.
Environ Sci Technol ; 52(5): 3275-3284, 2018 03 06.
Artículo en Inglés | MEDLINE | ID: mdl-29446927

RESUMEN

We assessed the gaseous, particulate, and genotoxic pollutants from two current technology gasoline direct injection vehicles when tested in their original configuration and with a catalyzed gasoline particulate filter (GPF). Testing was conducted over the LA92 and US06 Supplemental Federal Test Procedure (US06) driving cycles on typical California E10 fuel. The use of a GPF did not show any fuel economy and carbon dioxide (CO2) emission penalties, while the emissions of total hydrocarbons (THC), carbon monoxide (CO), and nitrogen oxides (NOx) were generally reduced. Our results showed dramatic reductions in particulate matter (PM) mass, black carbon, and total and solid particle number emissions with the use of GPFs for both vehicles over the LA92 and US06 cycles. Particle size distributions were primarily bimodal in nature, with accumulation mode particles dominating the distribution profile and their concentrations being higher during the cold-start period of the cycle. Polycyclic aromatic hydrocarbons (PAHs) and nitrated PAHs were quantified in both the vapor and particle phases of the PM, with the GPF-equipped vehicles practically eliminating most of these species in the exhaust. For the stock vehicles, 2-3 ring compounds and heavier 5-6 ring compounds were observed in the PM, whereas the vapor phase was dominated mostly by 2-3 ring aromatic compounds.


Asunto(s)
Contaminantes Atmosféricos , Hidrocarburos Policíclicos Aromáticos , California , Gasolina , Material Particulado , Emisiones de Vehículos
6.
Environ Sci Technol ; 51(3): 1868-1875, 2017 02 07.
Artículo en Inglés | MEDLINE | ID: mdl-28050905

RESUMEN

Ocean going vessels (OGVs) operating within emission control areas (ECA) are required to use fuels with ≤0.1 wt % sulfur. Up to now only distillate fuels could meet the sulfur limits. Recently refiners created a novel low-sulfur heavy-fuel oil (LSHFO) meeting the sulfur limits so questions were posed whether nitric oxide (NOx) and particulate matter (PM) emissions were the same for the two fuels. This project characterized criteria pollutants and undertook a detailed analysis of PM emissions from a very large crude oil carrier (VLCC) using a distillate ECA fuel (MGO) and novel LSHFO. Results showed emission factors of NOx were ∼5% higher with MGO than LSHFO. PM2.5 emission factors were ∼3 times higher with LSHFO than MGO, while both were below values reported by Lloyds, U.S. EPA and CARB. A detailed analysis of PM revealed it was >90% organic carbon (OC) for both fuels. Elemental carbon (EC) and soot measured with an AVL microsoot sensor (MSS) reflected black carbon. PM size distributions showed unimodal peaks for both MGO (20-30 nm) and LSHFO (30-50 nm). Particle number (PN) emissions were 28% and 17% higher with the PPS-M compared to the SMPS for LSHFO and MGO, respectively.


Asunto(s)
Contaminantes Atmosféricos , Aceites Combustibles , Contaminación del Aire , Tamaño de la Partícula , Material Particulado , Hollín , Emisiones de Vehículos
7.
Nature ; 539(7630): E8-E10, 2016 11 24.
Artículo en Inglés | MEDLINE | ID: mdl-27882979
8.
9.
Clin Immunol ; 158(2): 193-203, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25829232

RESUMEN

Genetic and environmental factors contribute to the onset and progression of lupus. CD4+ T cells from patients with active lupus show a decreased ERK signaling pathway, which causes changes in gene expression. The defect points to its upstream regulator, PKCδ, which exhibits a deficient activity due to oxidative stress. Our aim was to investigate the effect of a defective PKCδ in the development of lupus. We generated a double transgenic C57BL6 × SJL mouse that expresses a doxycycline-induced dominant negative PKCδ (dnPKCδ) in T cells. The transgenic mice displayed decreased T cell ERK signaling, decreased DNMT1 expression and overexpression of methylation sensitive genes involved in the exaggerated immune response in the pathogenesis of lupus. The mice developed anti-dsDNA autoantibodies and glomerulonephritis with IgG deposition. The study indicates common pathogenic mechanisms with human lupus, suggesting that environmentally-mediated T cell PKCδ inactivation plays a causative role in lupus.


Asunto(s)
Regulación Enzimológica de la Expresión Génica/inmunología , Lupus Eritematoso Sistémico/inmunología , Proteína Quinasa C-delta/metabolismo , Linfocitos T/enzimología , Animales , Antibacterianos/farmacología , Autoanticuerpos/metabolismo , Autoinmunidad , ADN (Citosina-5-)-Metiltransferasa 1 , ADN (Citosina-5-)-Metiltransferasas/genética , ADN (Citosina-5-)-Metiltransferasas/metabolismo , Doxiciclina/farmacología , Quinasas MAP Reguladas por Señal Extracelular/genética , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Glomerulonefritis/metabolismo , Inmunoglobulina G/metabolismo , Ratones , Ratones Transgénicos , Mutación , Fosforilación , Regiones Promotoras Genéticas , Proteína Quinasa C-delta/genética , Organismos Libres de Patógenos Específicos , Transactivadores
10.
J Pharmacol Exp Ther ; 353(2): 288-98, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25698787

RESUMEN

Small vessel vasculitis is a life-threatening condition and patients typically present with renal and pulmonary injury. Disease pathogenesis is associated with neutrophil accumulation, activation, and oxidative damage, the latter being driven in large part by myeloperoxidase (MPO), which generates hypochlorous acid among other oxidants. MPO has been associated with vasculitis, disseminated vascular inflammation typically involving pulmonary and renal microvasculature and often resulting in critical consequences. MPO contributes to vascular injury by 1) catabolizing nitric oxide, impairing vasomotor function; 2) causing oxidative damage to lipoproteins and endothelial cells, leading to atherosclerosis; and 3) stimulating formation of neutrophil extracellular traps, resulting in vessel occlusion and thrombosis. Here we report a selective 2-thiouracil mechanism-based MPO inhibitor (PF-1355 [2-(6-(2,5-dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide) and demonstrate that MPO is a critical mediator of vasculitis in mouse disease models. A pharmacokinetic/pharmacodynamic response model of PF-1355 exposure in relation with MPO activity was derived from mouse peritonitis. The contribution of MPO activity to vasculitis was then examined in an immune complex model of pulmonary disease. Oral administration of PF-1355 reduced plasma MPO activity, vascular edema, neutrophil recruitment, and elevated circulating cytokines. In a model of anti-glomerular basement membrane disease, formerly known as Goodpasture disease, albuminuria and chronic renal dysfunction were completely suppressed by PF-1355 treatment. This study shows that MPO activity is critical in driving immune complex vasculitis and provides confidence in testing the hypothesis that MPO inhibition will provide benefit in treating human vasculitic diseases.


Asunto(s)
Acetamidas/farmacología , Inhibidores Enzimáticos/farmacología , Membrana Basal Glomerular/efectos de los fármacos , Glomerulonefritis/prevención & control , Enfermedades del Complejo Inmune/prevención & control , Peroxidasa/antagonistas & inhibidores , Pirimidinas/farmacología , Pirimidinonas/farmacología , Vasculitis/prevención & control , Animales , Membrana Basal Glomerular/patología , Glomerulonefritis/enzimología , Glomerulonefritis/inmunología , Glomerulonefritis/patología , Humanos , Enfermedades del Complejo Inmune/enzimología , Enfermedades del Complejo Inmune/inmunología , Enfermedades del Complejo Inmune/patología , Pulmón/irrigación sanguínea , Pulmón/efectos de los fármacos , Pulmón/inmunología , Ratones , Infiltración Neutrófila/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Vasculitis/enzimología , Vasculitis/inmunología , Vasculitis/patología
11.
J Autoimmun ; 62: 75-80, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26165613

RESUMEN

Lupus develops when genetically predisposed people encounter environmental agents such as UV light, silica, infections and cigarette smoke that cause oxidative stress, but how oxidative damage modifies the immune system to cause lupus flares is unknown. We previously showed that oxidizing agents decreased ERK pathway signaling in human T cells, decreased DNA methyltransferase 1 and caused demethylation and overexpression of genes similar to those from patients with active lupus. The current study tested whether oxidant-treated T cells can induce lupus in mice. We adoptively transferred CD4(+) T cells treated in vitro with oxidants hydrogen peroxide or nitric oxide or the demethylating agent 5-azacytidine into syngeneic mice and studied the development and severity of lupus in the recipients. Disease severity was assessed by measuring anti-dsDNA antibodies, proteinuria, hematuria and by histopathology of kidney tissues. The effect of the oxidants on expression of CD40L, CD70, KirL1 and DNMT1 genes and CD40L protein in the treated CD4(+) T cells was assessed by Q-RT-PCR and flow cytometry. H2O2 and ONOO(-) decreased Dnmt1 expression in CD4(+) T cells and caused the upregulation of genes known to be suppressed by DNA methylation in patients with lupus and animal models of SLE. Adoptive transfer of oxidant-treated CD4(+) T cells into syngeneic recipients resulted in the induction of anti-dsDNA antibody and glomerulonephritis. The results show that oxidative stress may contribute to lupus disease by inhibiting ERK pathway signaling in T cells leading to DNA demethylation, upregulation of immune genes and autoreactivity.


Asunto(s)
Autoinmunidad/genética , Autoinmunidad/inmunología , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/metabolismo , Epigénesis Genética , Estrés Oxidativo/genética , Estrés Oxidativo/inmunología , Animales , Linfocitos T CD4-Positivos/efectos de los fármacos , Metilación de ADN , Modelos Animales de Enfermedad , Epigénesis Genética/efectos de los fármacos , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Glomerulonefritis/genética , Glomerulonefritis/inmunología , Glomerulonefritis/patología , Lupus Eritematoso Sistémico/genética , Lupus Eritematoso Sistémico/inmunología , Lupus Eritematoso Sistémico/patología , Ratones , Oxidantes/farmacología
12.
Am J Phys Anthropol ; 156(3): 349-62, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25363296

RESUMEN

Dental morphology provides important information on human evolution and interpopulation relationships. Dental wear is one of the major limitations of morphological data analysis. Wear figures heavily in existing debates about patterns of New World dental variation with some scholars finding evidence for a more generalized dentition in early New World populations (Powell: Doctoral Dissertation, Texas A&M University, TX (1995)) and others questioning these findings based on the probable effects of dental wear on trait scores (Turner, The First Americans: the Pleistocene Colonization of the New World. San Francisco: California Academy of Sciences (2002) 123-158; Turner: Am J Phys Anthropol 130 (2006) 455-461; Turner and Scott, Handbook of paleoanthropology, Vol. III: Phylogeny of Hominids. New York: Springer (2007) 1901-1941). Here we evaluate these competing claims using data from the Early Archaic Windover sample. Results confirm the dental distinctiveness of Windover with respect to other Old World Asian (i.e., sinodont/sundadont) populations. However, comparison of our results to those of Powell (1995) also highlights significant interobserver error. Statistical analysis of matched wear and morphology scores suggests trait downgrading for some traits. Patterns of missing data present a more challenging (and potentially serious) problem. Use of Little's MCAR test for missing data mechanisms indicates a complex process of data collection in which incidental and opportunistic recording of both highly worn and unerupted teeth introduce a "missing not at random" mechanism into our dataset that biases dental trait frequencies. We conclude that patterns of missingness and formal research designs for "planned missingness" are needed to help mitigate this bias.


Asunto(s)
Hominidae/anatomía & histología , Paleodontología , Desgaste de los Dientes/patología , Diente/anatomía & histología , Animales , Fósiles , Humanos , Paleodontología/métodos , Paleodontología/normas , Análisis de Componente Principal
13.
Am J Perinatol ; 32(1): 83-6, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24839147

RESUMEN

OBJECTIVE: To compare vancomycin serum trough concentrations and 24-hour area under the serum concentration-versus-time curve (AUC24) among very low-birth-weight (VLBW) premature infants before and after implementation of an institution-wide increase in neonatal vancomycin dosing. STUDY DESIGN: We performed a retrospective analysis of vancomycin concentrations among preterm VLBW neonates before (2007-2010) and after (2010-2013) implementation of a new vancomycin dosing protocol consisting of increased vancomycin daily dose and frequency of administration. RESULTS: Neonates weighing < 1,500 g and receiving the new vancomycin dosing regimen had lower rates of undetectable trough concentrations (24 vs. 50%, p = 0.04), higher median trough concentrations (10.8 vs. 5.9 µg/mL, p = 0.003), a higher proportion of goal trough concentrations of 10 to 20 µg/mL (35 vs. 4%, p = 0.005), and a significantly higher vancomycin AUC24 (438 vs. 320 mg·h/L, p = 0.004) compared with historical controls. CONCLUSION: Increasing the vancomycin daily dose and dosing frequency led to an increase in vancomycin trough concentrations and AUC24, and a decrease in the proportion of undetectable (< 5.0 µg/mL) troughs, without an increase in toxicity among VLBW premature neonates.


Asunto(s)
Antibacterianos/administración & dosificación , Bacteriemia/tratamiento farmacológico , Enterocolitis Necrotizante/tratamiento farmacológico , Vancomicina/administración & dosificación , Antibacterianos/farmacocinética , Estudios de Cohortes , Femenino , Humanos , Recien Nacido Extremadamente Prematuro , Recién Nacido , Recien Nacido Prematuro , Recién Nacido de muy Bajo Peso , Masculino , Estudios Retrospectivos , Vancomicina/farmacocinética
14.
Environ Sci Technol ; 48(3): 1779-86, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24328166

RESUMEN

It is important to understand the differences between emissions from standard laboratory testing cycles and those from actual on-road driving conditions, especially for solid particle number (SPN) emissions now being regulated in Europe. This study compared particle mass and SPN emissions from a heavy-duty diesel vehicle operating over the urban dynamometer driving schedule (UDDS) and actual on-road driving conditions. Particle mass emissions were calculated using the integrated particle size distribution (IPSD) method and called MIPSD. The MIPSD emissions for the UDDS and on-road tests were more than 6 times lower than the U.S. 2007 heavy-duty particulate matter (PM) mass standard. The MIPSD emissions for the UDDS fell between those for the on-road uphill and downhill driving. SPN and MIPSD measurements were dominated by nucleation particles for the UDDS and uphill driving and by accumulation mode particles for cruise and downhill driving. The SPN emissions were ∼ 3 times lower than the Euro 6 heavy-duty SPN limit for the UDDS and downhill driving and ∼ 4-5 times higher than the Euro 6 SPN limit for the more aggressive uphill driving; however, it is likely that most of the "solid" particles measured under these conditions were associated with a combination release of stored sulfates and enhanced sulfate formation associated with high exhaust temperatures, leading to growth of volatile particles into the solid particle counting range above 23 nm. Except for these conditions, a linear relationship was found between SPN and accumulation mode MIPSD. The coefficient of variation (COV) of SPN emissions of particles >23 nm ranged from 8 to 26% for the UDDS and on-road tests.


Asunto(s)
Contaminantes Atmosféricos/análisis , Material Particulado/análisis , Emisiones de Vehículos/análisis , Conducción de Automóvil , Peso Molecular , Tamaño de la Partícula
15.
Environ Sci Technol ; 48(23): 14016-24, 2014 Dec 02.
Artículo en Inglés | MEDLINE | ID: mdl-25375668

RESUMEN

This study investigated the effects of higher ethanol blends and an isobutanol blend on the criteria emissions, fuel economy, gaseous toxic pollutants, and particulate emissions from two flexible-fuel vehicles equipped with spark ignition engines, with one wall-guided direct injection and one port fuel injection configuration. Both vehicles were tested over triplicate Federal Test Procedure (FTP) and Unified Cycles (UC) using a chassis dynamometer. Emissions of nonmethane hydrocarbons (NMHC) and carbon monoxide (CO) showed some statistically significant reductions with higher alcohol fuels, while total hydrocarbons (THC) and nitrogen oxides (NOx) did not show strong fuel effects. Acetaldehyde emissions exhibited sharp increases with higher ethanol blends for both vehicles, whereas butyraldehyde emissions showed higher emissions for the butanol blend relative to the ethanol blends at a statistically significant level. Particulate matter (PM) mass, number, and soot mass emissions showed strong reductions with increasing alcohol content in gasoline. Particulate emissions were found to be clearly influenced by certain fuel parameters including oxygen content, hydrogen content, and aromatics content.


Asunto(s)
Contaminantes Atmosféricos/química , Butanoles/química , Etanol/química , Gasolina/análisis , Emisiones de Vehículos/análisis , Monóxido de Carbono/análisis , Conservación de los Recursos Energéticos , Efecto Invernadero , Hidrocarburos/análisis , Óxidos de Nitrógeno/análisis , Material Particulado/análisis , Hollín
16.
Arthritis Rheum ; 65(7): 1872-81, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23576011

RESUMEN

OBJECTIVE: Lupus flares occur when genetically predisposed individuals encounter appropriate environmental agents. Current evidence indicates that the environment contributes by inhibiting T cell DNA methylation, causing overexpression of normally silenced genes. DNA methylation depends on both dietary transmethylation micronutrients and ERK-regulated DNA methyltransferase 1 (DNMT-1) levels. We used transgenic mice to study the effect of interactions between diet, DNMT-1 levels, and genetic predisposition on the development and severity of lupus. METHODS: A doxycycline-inducible ERK defect was bred into lupus-resistant (C57BL/6) and lupus-susceptible (C57BL/6 × SJL) mouse strains. Doxycycline-treated mice were fed a standard commercial diet for 18 weeks and then switched to a transmethylation micronutrient-supplemented (MS) or -restricted (MR) diet. Disease severity was assessed by examining anti-double-stranded DNA (anti-dsDNA) antibody levels, the presence of proteinuria and hematuria, and by histopathologic analysis of kidney tissues. Pyrosequencing was used to determine micronutrient effects on DNA methylation. RESULTS: Doxycycline induced modest levels of anti-dsDNA antibodies in C57BL/6 mice and higher levels in C57BL/6 × SJL mice. Doxycycline-treated C57BL/6 × SJL mice developed hematuria and glomerulonephritis on the MR and standard diets but not the MS diet. In contrast, C57BL/6 mice developed kidney disease only on the MR diet. Decreasing ERK signaling and methyl donors also caused demethylation and overexpression of the CD40lg gene in female mice, consistent with demethylation of the second X chromosome. Both the dietary methyl donor content and the duration of treatment influenced methylation and expression of the CD40lg gene. CONCLUSION: Dietary micronutrients that affect DNA methylation can exacerbate or ameliorate disease in this transgenic murine lupus model, and contribute to lupus susceptibility and severity through genetic-epigenetic interactions.


Asunto(s)
Anticuerpos Antinucleares/inmunología , ADN (Citosina-5-)-Metiltransferasas/metabolismo , Metilación de ADN/fisiología , Dieta , Lupus Eritematoso Sistémico/genética , Micronutrientes , Animales , Betaína , Ligando de CD40/metabolismo , Colina , Coenzimas , ADN (Citosina-5-)-Metiltransferasa 1 , Metilación de ADN/genética , Modelos Animales de Enfermedad , Epigénesis Genética , Ácido Fólico , Silenciador del Gen , Predisposición Genética a la Enfermedad , Lupus Eritematoso Sistémico/inmunología , Metionina , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Riboflavina , Vitamina B 12 , Vitamina B 6 , Zinc
17.
Ann Rheum Dis ; 72(8): 1342-50, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22975753

RESUMEN

OBJECTIVE: To identify circulating proteins that distinguish between active anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and remission in a manner complementary to markers of systemic inflammation. METHODS: Twenty-eight serum proteins representing diverse aspects of the biology of AAV were measured before and 6 months after treatment in a large clinical trial of AAV. Subjects (n=186) enrolled in the Rituximab in ANCA-Associated Vasculitis (RAVE) trial were studied. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were available for comparison. The primary outcome was the ability of markers to distinguish severe AAV (Birmingham Vasculitis Activity Score for Wegener's granulomatosis (BVAS/WG)≥3 at screening) from remission (BVAS/WG=0 at month 6), using areas under receiver operating characteristic (ROC) curve (AUC). RESULTS: All subjects had severe active vasculitis (median BVAS/WG=8) at screening. In the 137 subjects in remission at month 6, 24 of the 28 markers showed significant declines. ROC analysis indicated that levels of CXCL13 (BCA-1), matrix metalloproteinase-3 (MMP-3) and tissue inhibitor of metalloproteinases-1 (TIMP-1) best discriminated active AAV from remission (AUC>0.8) and from healthy controls (AUC>0.9). Correlations among these markers and with ESR or CRP were low. CONCLUSIONS: Many markers are elevated in severe active AAV and decline with treatment, but CXCL13, MMP-3 and TIMP-1 distinguish active AAV from remission better than the other markers studied, including ESR and CRP. These proteins are particularly promising candidates for future studies to address unmet needs in the assessment of patients with AAV.


Asunto(s)
Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/sangre , Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/patología , Proteínas/metabolismo , Adulto , Anciano , Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/tratamiento farmacológico , Anticuerpos Monoclonales de Origen Murino/uso terapéutico , Biomarcadores/sangre , Sedimentación Sanguínea , Proteína C-Reactiva/análisis , Quimiocina CXCL13/sangre , Quimiocinas/sangre , Citocinas/sangre , Método Doble Ciego , Femenino , Estado de Salud , Humanos , Factores Inmunológicos/uso terapéutico , Masculino , Metaloproteinasa 3 de la Matriz/sangre , Persona de Mediana Edad , Curva ROC , Inducción de Remisión , Rituximab , Índice de Severidad de la Enfermedad , Inhibidor Tisular de Metaloproteinasa-1/sangre
18.
J Air Waste Manag Assoc ; 73(7): 568-577, 2023 07.
Artículo en Inglés | MEDLINE | ID: mdl-37093027

RESUMEN

Tailpipe PM (particulate matter) emissions have been reduced due to decades of tightening regulations, however non-tailpipe PM emissions are not regulated and are expected to become a significant source of traffic-related PM emissions. Previous studies have focused on emission measurement from laboratory and track tests. Their findings suggest brake wear PM emission rates are dependent on brake activity. Therefore, it is important to characterize brake emissions by first understanding the real-world brake activity from many different vehicle vocations and driving conditions. The goal of the current study is to establish a test method and analysis for brake activity measurements of heavy-duty vehicles. In this study, brake fluid pressure and brake pad temperature were measured for a heavy-duty vehicle during chassis and on-road driving tests. The chassis tests consisted of the Central Business District (CBD) cycle representative of a repetitive stop-and-go driving pattern of a bus, and the Urban Dynamometer Driving Schedule (UDDS) cycle representative of urban driving conditions of heavy-duty vehicles. The on-road tests consisted of a local Riverside City route focused on urban roads at low vehicle speeds with frequent braking, while the second route from Riverside City to Victorville focused on highway driving and downhill braking. The brake pad temperature of the triplicate CBD cycle gradually increased linearly with a slope of 2.3°C/min and the temperature per kinetic energy lost during braking increased by 2.3 × 10-5°C/J for the CBD cycle. The UDDS cycles had the largest kinetic energy loss between 3.2 × 103 to 3.0 × 105 J in the histogram. The local Riverside city route brake temperature increased by 2.0°C/min. The kinetic energy loss for the on-road tests were one order of magnitude larger than that of the dynamometer tests due to brake events occurring under higher speeds.Implications: The non-tailpipe source contributions to traffic related particulate matter (PM) emissions have surpassed that of tailpipe emissions. The results of this work provide a measurement method to obtain brake activity information for a heavy-duty vehicle, which is critical estimating emission inventory accurately.


Asunto(s)
Contaminantes Atmosféricos , Contaminantes Atmosféricos/análisis , Emisiones de Vehículos/análisis , Monitoreo del Ambiente , Material Particulado/análisis , Ciudades , Vehículos a Motor
19.
J Autoimmun ; 38(2-3): J135-43, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22142890

RESUMEN

Systemic lupus erythematosus (SLE) is an autoimmune disease primarily afflicting women. The reason for the gender bias is unclear, but genetic susceptibility, estrogen and environmental agents appear to play significant roles in SLE pathogenesis. Environmental agents can contribute to lupus susceptibility through epigenetic mechanisms. We used (C57BL/6xSJL)F1 mice transgenic for a dominant-negative MEK (dnMEK) that was previously shown to be inducibly and selectively expressed in T cells. In this model, induction of the dnMEK by doxycycline treatment suppresses T cell ERK signaling, decreasing DNA-methyltransferase expression and resulting in DNA demethylation, overexpression of immune genes Itgal (CD11a) and Tnfsf7 (CD70), and anti-dsDNA antibody. To examine the role of gender and estrogen in this model, male and female transgenic mice were neutered and implanted with time-release pellets delivering placebo or estrogen. Doxycycline induced IgG anti-dsDNA antibodies in intact and neutered, placebo-treated control female but not male transgenic mice. Glomerular IgG deposits were also found in the kidneys of female but not male transgenic mice, and not in the absence of doxycycline. Estrogen enhanced anti-dsDNA IgG antibodies only in transgenic, ERK-impaired female mice. Decreased ERK activation also resulted in overexpression and demethylation of the X-linked methylation-sensitive gene CD40lg in female but not male mice, consistent with demethylation of the second X chromosome in the females. The results show that both estrogen and female gender contribute to the female predisposition in lupus susceptibility through hormonal and epigenetic X-chromosome effects and through suppression of ERK signaling by environmental agents.


Asunto(s)
Epigénesis Genética , Estrógenos/toxicidad , Interacción Gen-Ambiente , Lupus Eritematoso Sistémico/genética , Cromosoma X , Animales , Anticuerpos Antinucleares/sangre , Anticuerpos Antinucleares/inmunología , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/metabolismo , Metilación de ADN , Modelos Animales de Enfermedad , Exposición a Riesgos Ambientales , Femenino , Expresión Génica , Lupus Eritematoso Sistémico/etiología , Lupus Eritematoso Sistémico/inmunología , Lupus Eritematoso Sistémico/patología , Nefritis Lúpica/inmunología , Nefritis Lúpica/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Factores Sexuales
20.
J Nutr ; 142(7): 1329-35, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22649261

RESUMEN

Prenatal environmental exposures play a critical role in determining late-life chronic disease susceptibility. However, the mechanisms linking the in utero environment and disease development in the offspring are poorly understood. Recent investigations have confirmed a central pathogenic role of T cell chemokine receptors, particularly C-C chemokine receptor (CCR) 2 and CCR5, in chronic inflammatory conditions. This study was designed to determine the effect of a synthetic prenatal micronutrient supplementation (MS) diet rich in methionine pathway metabolites on the T cell chemokine system in F1 C57Bl/6 mice. Female mice were fed either an MS or control diet 3 wk prior to mating, during pregnancy, and lactation. At 4 wk of age, F1 mice were killed for experiments or were fed the standard NIH-31 diet and allowed to age. Food consumption, maternal weight gain, and litter size were similar in dams fed the control and MS diets. However, the F1 offspring of dams fed the MS diet were smaller in size (P < 0.001). T cells from the MS F1 offspring had global hypermethylation compared with control F1 offspring (P < 0.005), corresponding to lower T cell chemokine receptor expression [CCR2 (P < 0.001), CCR5 (P < 0.001), and C-x-C chemokine receptor 3 (P < 0.01)] and cytokine expression [TNFα (P < 0.05), IL-2 (P < 0.001), and IL-4 (P < 0.01)]. Reduced T cell chemokine receptor gene expression in MS F1 mice was associated with decreased chemotaxis in vitro to C-C chemokine ligand (CCL) 2 and C-X-C chemokine ligand 10 (P < 0.01) and in vivo to CCL2 (P < 0.01). Taken together, the results suggest that epigenetic alteration through prenatal diet manipulation reduces the response to proinflammatory signals in mice.


Asunto(s)
Expresión Génica/efectos de los fármacos , Crecimiento/efectos de los fármacos , Inflamación/prevención & control , Micronutrientes/farmacología , Fenómenos Fisiologicos de la Nutrición Prenatal/efectos de los fármacos , Receptores de Antígenos de Linfocitos T/metabolismo , Receptores de Quimiocina/metabolismo , Animales , Quimiotaxis/efectos de los fármacos , Citocinas/genética , Citocinas/metabolismo , Metilación de ADN/efectos de los fármacos , Dieta , Suplementos Dietéticos , Epigénesis Genética , Femenino , Crecimiento/genética , Inflamación/genética , Inflamación/metabolismo , Metionina/metabolismo , Ratones , Ratones Endogámicos C57BL , Embarazo , Atención Prenatal , Fenómenos Fisiologicos de la Nutrición Prenatal/inmunología , Receptores de Antígenos de Linfocitos T/antagonistas & inhibidores , Receptores de Antígenos de Linfocitos T/genética , Receptores de Quimiocina/antagonistas & inhibidores , Receptores de Quimiocina/genética , Transducción de Señal/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA